VIVS VivoSim Labs, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$0,20
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,19mínimo 52 semanas
$3,54máximo 52 semanas
Capitalización Bursátil (MRQ)
$627.4K
P/E (TTM)
-0.0
BPA (TTM)
$-4.46
Ingresos (TTM)
$112.0K
tus insignias
Rango 52S
$0–$4
Calificación del Analista
HOLD
Precio Objetivo
·
P/E
-0.0
ROE
-343.1%
Margen de Beneficio Neto
-11016.1%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
VIVS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.20
Capitalización Bursátil (MRQ)
$627.4K
P/E (TTM)
-0.0
BPA (TTM)
$-4.46
Ingresos (TTM)
$112.0K
ROE (TTM)
-343.1%
Rango 52S
$0–$4
VIVS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 21 de marzo de 2025 | 1-for-12 | Inversa |
| 19 de agosto de 2020 | 1-for-20 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$131.0K2017-03-31 → 2026-03-31
BPA$-5.352022-03-31 → 2026-03-31
Flujo de caja libre$-11M2017-03-31 → 2026-03-31
Margen neto-11016.1%2017-03-31 → 2026-03-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | VIVS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -0.0promedio 5A ≈-9.9 | ≈-9.9 | · | · | |
| P/S (TTM) | 5.6 | · | 4.6 | Sobrevalorado | |
| P/C (MRQ) | -0.3 | · | · | · | |
| Precio / FCF (TTM) | -0.1 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -0.1 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.1promedio 5A ≈15.7 | ≈15.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | VIVS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -10117.0% | · | -1012.6% | Débil | |
| Margen EBITDA (TTM) | -9943.8% | · | -1011.2% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -10565.6% | · | -5290.5% | Débil | |
| Margen de Beneficio Neto (TTM) | -11016.1% | · | -952.6% | Débil | |
| ROA (TTM) | -155.9% | · | -121.4% | Débil | |
| ROE (TTM) | -343.1% | · | -294.8% | En línea | |
| ROIC | 1045.4% | · | -113.3% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | VIVS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.7 | · | 2.1 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 1.8 | · | 1.8 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | VIVS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -9.0%promedio 5A ≈-30.7% | ≈-30.7% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -29.3% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | VIVS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0 | · | 0.0 | Débil | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 4.2 | · | 4.6 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$8.7K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-183.7%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 31 de marzo de 2025 | $-2.21 | $-0.19 | -1040.4% | |
| 31 de diciembre de 2024 | $-2.29 | $-2.57 | 10.8% | |
| 30 de septiembre de 2024 | $-1.68 | $-3.18 | 47.2% | |
| 30 de junio de 2024 | $-2.76 | $-4.04 | 31.7% | |
| 31 de marzo de 2024 | $-3.48 | $-5.14 | 32.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $131.0K | $144.0K | $109.0K | $370.0K | $2M | $0 | $2M | $3M | $5M | $4M | $1M | $571.0K | |
| Cost of Revenue | $0 | $5.0K | · | · | · | $0 | $328.0K | $482.0K | $1M | $956.0K | $0 | $0 | |
| R&D Expense | $4M | $5M | $5M | $9M | $3M | $1M | $5M | $15M | $18M | $20M | $18M | $13M | |
| SG&A Expense | $7M | $8M | $10M | $9M | $10M | $16M | $18M | $15M | $21M | $22M | $22M | $18M | |
| Operating Expenses | $12M | $13M | $15M | $18M | $13M | $17M | $24M | $30M | $40M | $43M | $40M | $31M | |
| Operating Income | $-11M | $-13M | $-15M | $-18M | $-11M | $-17M | $-21M | $-27M | $-35M | $-39M | $-39M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $0 | $1.0K | |
| Interest Income | $267.0K | $140.0K | $405.0K | $454.0K | $8.0K | $15.0K | $594.0K | $705.0K | $478.0K | $198.0K | $88.0K | $32.0K | |
| Other Non-op | $-2M | $10M | $417.0K | $474.0K | $25.0K | $6.0K | $2M | $0 | $-12.0K | $0 | $0 | $215.0K | |
| Pretax Income | $-14M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $3.0K | $2.0K | $23.0K | $3.0K | $0 | |
| Net Income | $-14M | $-2M | $-15M | $-17M | $-11M | $-17M | $-19M | $-27M | $-35M | $-38M | $-39M | $-30M | |
| EPS (Basic) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | · | · | · | · | · | · | · | |
| Shares (Basic) | 2,588,327 | 1,463,609 | 762,076 | 8,713,032 | 8,703,596 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 2,588,327 | 1,463,609 | 762,076 | 8,713,032 | 8,703,596 | · | · | · | · | · | · | · | |
| EBITDA | $-11M | · | · | · | $-11M | · | · | $-26M | $-34M | $-37M | $-38M | $-30M |
Balance general
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $11M | $3M | $15M | $29M | $37M | $27M | $36M | $44M | $63M | $62M | $50M | |
| Short-term Investments | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Receivables | $32.0K | $30.0K | $33.0K | $152.0K | $0 | $0 | $111.0K | $503.0K | $883.0K | $647.0K | $259.0K | $0 | |
| Inventory | · | $0 | $297.0K | $0 | · | · | $0 | $490.0K | $842.0K | $550.0K | $334.0K | $66.0K | |
| Prepaid Expense | $557.0K | $789.0K | $705.0K | $889.0K | $858.0K | $1M | $851.0K | $1M | $1M | $1M | $968.0K | $1M | |
| Other Current Assets | $0 | $12.0K | $4.0K | $69.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $7M | $12M | $4M | $17M | $30M | $38M | $28M | $39M | $47M | $65M | $64M | $51M | |
| PP&E (Net) | $206.0K | $419.0K | $669.0K | $902.0K | $662.0K | $381.0K | $0 | $2M | $3M | $4M | $4M | $2M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $415.0K | $6M | $7M | $7M | $6M | $3M | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $415.0K | $5M | $4M | $3M | $2M | $1M | |
| Other Non-current Assets | · | · | · | · | · | $1M | $123.0K | $138.0K | $152.0K | $121.0K | $134.0K | $106.0K | |
| Total Assets | $7M | $15M | $6M | $20M | $33M | $40M | $28M | $41M | $50M | $69M | $68M | $53M | |
| Accounts Payable | $1M | $2M | $627.0K | $331.0K | $415.0K | $281.0K | $720.0K | $628.0K | $464.0K | $1M | $787.0K | $1M | |
| Accrued Liabilities | $981.0K | $1M | $727.0K | $3M | $489.0K | $440.0K | $1M | $3M | $3M | $4M | $2M | $2M | |
| Current Liabilities | $3M | $4M | $2M | $4M | $1M | $721.0K | $2M | $4M | $5M | $6M | $4M | $5M | |
| Capital Leases | $0 | $421.0K | $888.0K | $1M | $2M | $0 | · | $0 | · | · | · | $0 | |
| Total Liabilities | $8M | $4M | $3M | $5M | $3M | $721.0K | $2M | $4M | $5M | $7M | $5M | $5M | |
| Common Stock | $3.0K | $2.0K | $1.0K | $9.0K | $9.0K | $9.0K | $7.0K | $124.0K | $111.0K | $104.0K | $92.0K | $82.0K | |
| Retained Earnings | $-356M | $-342M | $-340M | $-325M | $-308M | $-296M | $-279M | $-261M | $-234M | $-199M | $-161M | $-122M | |
| Treasury Stock | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | · | · | · | · | · | |
| AOCI | · | · | $0 | $2.0K | $0 | · | · | · | $0 | $-11.0K | $0 | · | |
| Stockholders' Equity | $-1M | $10M | $4M | $15M | $30M | $39M | $27M | $36M | $45M | $62M | $62M | $49M | |
| Liabilities + Equity | $7M | $15M | $6M | $20M | $33M | $40M | $28M | $41M | $50M | $69M | $68M | $53M | |
| Shares Outstanding | 2,894,519 | 1,898,068 | 839,814 | 8,716,906 | 8,710,627 | 8,670,492 | 6,527,905 | 124,015,429 | 111,032,957 | 104,551,466 | 104,551,466 | 81,536,724 |
Flujo de Efectivo
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $215.0K | $266.0K | $280.0K | $293.0K | $142.0K | $41.0K | $1M | $980.0K | $1M | $1M | $815.0K | $472.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $7M | $7M | $9M | $7M | |
| Other Non-cash | $3M | · | · | · | $3M | · | · | $5M | $-2M | $721.0K | $-164.0K | $3M | |
| Operating Cash Flow | $-11M | $-9M | $-15M | $-12M | $-8M | $-13M | $-15M | $-20M | $-29M | $-29M | $-29M | $-20M | |
| CapEx | $0 | $13.0K | $42.0K | $396.0K | $409.0K | $405.0K | $0 | $79.0K | $226.0K | $1M | $2M | $2M | |
| Investing Cash Flow | $94.0K | $9M | $816.0K | $-966.0K | $-409.0K | $-393.0K | $747.0K | $-76.0K | $-292.0K | · | · | · | |
| Stock Issued | $5M | $9M | $1M | $0 | $251.0K | $24M | $5M | $13M | $9M | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $1.0K | $0 | · | · | · | · | · | |
| Net Stock Activity | $5M | · | · | · | $251.0K | · | · | $13M | · | · | · | · | |
| Financing Cash Flow | $4M | $9M | $1M | $0 | $205.0K | $24M | $5M | $13M | $10M | · | · | · | |
| Net Change in Cash | $-6M | $8M | $-12M | $-13M | $-9M | $10M | $-9M | $-7M | $-19M | $660.0K | $12M | $2M | |
| Free Cash Flow | $-11M | · | · | · | $-9M | · | · | $-20M | $-29M | $-31M | $-31M | $-21M |
Rentabilidad
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8768.7% | · | · | · | -765.3% | · | · | -882.4% | -766.3% | -911.9% | -2605.7% | -5305.9% | |
| Net Margin | -10567.2% | · | · | · | -763.2% | · | · | -861.7% | -756.1% | -908.9% | -2601.2% | -5268.3% | |
| Pretax Margin | -10565.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -8604.6% | · | · | · | -755.8% | · | · | -850.7% | -738.7% | -884.8% | -2550.8% | -5223.3% | |
| ROA | -125.6% | · | · | · | -31.3% | · | · | -58.9% | -58.5% | -56.2% | -63.7% | -58.0% | |
| ROE | -294.8% | · | · | · | -33.0% | · | · | -65.9% | -65.1% | -61.7% | -69.6% | -62.0% | |
| ROIC | 1045.4% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | · | · | 21.4 | · | · | 10.3 | 10.0 | 10.8 | 14.2 | 10.8 | |
| Quick Ratio | 1.8 | · | · | · | 20.7 | · | · | 9.9 | 9.6 | 10.5 | 13.9 | 10.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -30297.0 |
Eficiencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 | · | · | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.7 | 1.5 | 2.2 | · | · | |
| Receivables Turnover | 4.2 | · | · | · | · | · | · | 4.5 | 6.0 | 9.3 | 11.5 | · |
Por Acción
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.38 | · | · | · | $3.47 | · | · | $0.29 | $0.40 | $0.60 | $0.67 | $0.60 | |
| Revenue / Share | $0.05 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-4.18 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.74 | · | · | · | $3.29 | · | · | $0.29 | $0.39 | $0.60 | $0.67 | $0.61 | |
| EPS (TTM) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | $1.24 | $1.24 | $1.24 | $1.24 | $1.24 | $1.24 | $1.24 |
Tasas de Crecimiento
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -9.0% | 32.1% | -70.5% | -75.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -29.3% | -54.2% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $131.0K | $144.0K | $109.0K | $370.0K | $2M | $0 | $2M | $3M | $5M | $4M | $1M | $571.0K | |
| Net Income TTM | $-14M | $-2M | $-15M | $-17M | $-11M | $-17M | $-19M | $-27M | $-35M | $-38M | $-39M | $-30M | |
| Market Cap | $4M | · | · | · | $393M | · | · | $29.47B | $27.45B | $79.79B | $48.12B | $69.27B | |
| P/E | -0.3 | -1.3 | -0.6 | -13.3 | -34.2 | 93.3 | 79.4 | 191.6 | 199.4 | 615.5 | 420.0 | 685.2 | |
| P/S | 31.6 | · | · | · | 262.0 | · | · | 9532.9 | 5962.9 | 18863.8 | 32446.2 | 121319.8 | |
| P/B | -3.8 | · | · | · | 13.0 | · | · | 811.8 | 615.6 | 1279.5 | 773.8 | 1422.6 | |
| P / Tangible Book | · | 0.4 | 34.6 | 14.9 | 13.0 | 25.6 | · | · | · | · | · | · | |
| P / Cash Flow | -0.4 | · | · | · | -46.5 | · | · | -1446.2 | -951.2 | -2734.1 | -1638.4 | -3534.2 | |
| P / FCF | -0.4 | · | · | · | -44.3 | · | · | -1440.6 | -943.8 | -2612.8 | -1528.4 | -3280.3 | |
| Earnings Yield | -374.1% | -75.9% | -155.7% | -7.5% | -2.9% | 1.1% | 1.3% | 0.52% | 0.50% | 0.16% | 0.24% | 0.15% |
Estado de resultados
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.0K | $40.0K | $26.0K | $28.0K | $37.0K | $51.0K | $24.0K | $30.0K | $39.0K | $29.0K | $5.0K | $0 | $75.0K | $162.0K | $131.0K | $77.0K | |
| Cost of Revenue | · | $0 | $0 | $0 | $0 | $0 | $2.0K | $1.0K | $2.0K | · | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $1M | $1M | $1M | $923.0K | $1M | $859.0K | $2M | $984.0K | $1M | $1M | $1M | $1M | $2M | $5M | $1M | $1M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $8M | $3M | $3M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-8M | $-3M | $-3M | |
| Interest Income | $28.0K | $36.0K | $63.0K | $92.0K | $76.0K | $11.0K | $26.0K | $59.0K | $44.0K | $51.0K | $76.0K | $121.0K | $157.0K | $177.0K | $143.0K | $103.0K | |
| Other Non-op | $1M | $-3M | $59.0K | $92.0K | $72.0K | $10M | $21.0K | $59.0K | $44.0K | $51.0K | $76.0K | $121.0K | $169.0K | $320.0K | $95.0K | $33.0K | |
| Income Tax | $3.0K | $0 | $0 | $2.0K | $0 | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | |
| Net Income | $-1M | $-6M | $-3M | $-3M | $-3M | $7M | $-3M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-7M | $-3M | $-3M | |
| EPS (Basic) | $-0.25 | $-2.20 | $-1.03 | $-0.98 | $-1.14 | $5.00 | $-2.28 | $-1.68 | $-2.74 | $-17.93 | $-0.40 | $-0.46 | $-0.46 | $-0.86 | $-0.37 | $-0.38 | |
| EPS (Diluted) | $-0.25 | $-2.20 | $-1.03 | $-0.98 | $-1.14 | $5.00 | $-2.28 | $-1.68 | $-2.74 | $-17.93 | $-0.40 | $-0.46 | $-0.46 | $-0.86 | $-0.37 | $-0.38 | |
| Shares (Basic) | 5,239,462 | · | 2,607,962 | 2,604,950 | 2,503,697 | · | 1,504,713 | 1,499,544 | 1,221,974 | · | 9,115,455 | 8,718,502 | 8,717,232 | · | 8,713,617 | 8,712,284 | |
| Shares (Diluted) | 5,239,462 | · | 2,607,962 | 2,604,950 | 2,503,697 | · | 1,504,713 | 1,499,544 | 1,221,974 | · | 9,115,455 | 8,718,502 | 8,717,232 | · | 8,713,617 | 8,712,284 | |
| EBITDA | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | $-3M | $-3M | · | $-4M | $-4M | $-4M | · | $-3M | $-3M |
Balance general
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $4M | $7M | $9M | $11M | $1M | $3M | $6M | $3M | $5M | $8M | $11M | $15M | $20M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Receivables | $29.0K | $32.0K | $33.0K | $32.0K | $32.0K | $30.0K | $26.0K | $29.0K | $48.0K | $33.0K | $33.0K | $55.0K | $149.0K | $152.0K | $76.0K | · | |
| Inventory | · | · | · | · | · | $0 | $0 | $640.0K | $408.0K | $297.0K | · | · | · | $0 | · | · | |
| Prepaid Expense | $511.0K | $557.0K | $709.0K | $882.0K | $592.0K | $789.0K | $913.0K | $940.0K | $640.0K | $705.0K | $913.0K | $624.0K | $792.0K | $889.0K | $788.0K | $519.0K | |
| Other Current Assets | · | $0 | · | · | · | $12.0K | · | · | · | $4.0K | · | · | · | $69.0K | · | · | |
| Current Assets | $3M | $7M | $6M | $8M | $10M | $12M | $2M | $5M | $7M | $4M | $6M | $8M | $12M | $17M | $22M | $24M | |
| PP&E (Net) | $189.0K | $206.0K | $248.0K | $300.0K | $359.0K | $419.0K | $479.0K | $545.0K | $601.0K | $669.0K | $739.0K | $808.0K | $850.0K | $902.0K | $742.0K | $758.0K | |
| PP&E (Gross) | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | |
| Accum. Depreciation | · | $2M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Total Assets | $4M | $7M | $7M | $10M | $12M | $15M | $4M | $7M | $9M | $6M | $9M | $11M | $15M | $20M | $25M | $28M | |
| Accounts Payable | $621.0K | $1M | $671.0K | $580.0K | $673.0K | $2M | $930.0K | $419.0K | $1M | $627.0K | $471.0K | $435.0K | $488.0K | $331.0K | $242.0K | $441.0K | |
| Accrued Liabilities | $738.0K | $981.0K | $818.0K | $771.0K | $727.0K | $1M | $1M | $879.0K | $404.0K | $727.0K | $727.0K | $666.0K | $787.0K | $3M | $646.0K | $462.0K | |
| Current Liabilities | $2M | $3M | $2M | $2M | $2M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $1M | $1M | |
| Capital Leases | $0 | $0 | $44.0K | $172.0K | $298.0K | $421.0K | $543.0K | $660.0K | $775.0K | $888.0K | $999.0K | $1M | $1M | $1M | $1M | $2M | |
| Total Liabilities | $6M | $8M | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | $3M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $17.0K | $15.0K | $14.0K | $1.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | |
| Retained Earnings | $-357M | $-356M | $-350M | $-348M | $-345M | $-342M | $-349M | $-346M | $-343M | $-340M | $-337M | $-333M | $-329M | $-325M | $-318M | $-314M | |
| Treasury Stock | · | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| AOCI | · | · | · | · | · | · | · | $1.0K | · | · | $1.0K | $1.0K | $2.0K | $2.0K | $3.0K | · | |
| Stockholders' Equity | $-2M | $-1M | $4M | $7M | $10M | $10M | $364.0K | $4M | $7M | $4M | $6M | $8M | $12M | $15M | $22M | $25M | |
| Liabilities + Equity | $4M | $7M | $7M | $10M | $12M | $15M | $4M | $7M | $9M | $6M | $9M | $11M | $15M | $20M | $25M | $28M | |
| Shares Outstanding | 3,194,295 | 2,894,519 | 2,607,962 | 2,607,962 | 2,599,797 | 1,898,068 | 17,133,346 | 15,365,825 | 14,373,076 | 839,814 | 9,838,755 | 8,719,453 | 8,718,203 | 8,716,906 | 8,714,590 | 8,713,268 |
Flujo de Efectivo
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40.0K | $43.0K | $52.0K | $59.0K | $61.0K | $61.0K | $67.0K | $68.0K | $70.0K | $71.0K | $71.0K | $71.0K | $67.0K | $59.0K | $130.0K | $54.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Other Non-cash | $-2M | · | · | · | $-1M | · | · | · | $291.0K | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-3M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $23.0K | $0 | $0 | $0 | $0 | $0 | $0 | $13.0K | $0 | $0 | $0 | $27.0K | $15.0K | $162.0K | $41.0K | $119.0K | |
| Investing Cash Flow | $-23.0K | $94.0K | $0 | $0 | $0 | $9M | $4.0K | $0 | $20.0K | $13.0K | $27.0K | $12.0K | $764.0K | $-162.0K | $10M | $-86.0K | |
| Stock Issued | $0 | $3M | $0 | $0 | $2M | $3M | $-216.0K | $-371.0K | $6M | $264.0K | $1M | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | $0 | · | · | · | $2M | · | · | · | $6M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-118.0K | $3M | $-118.0K | $0 | $2M | $3M | $-216.0K | $-371.0K | $6M | $264.0K | $1M | $0 | $0 | $0 | $0 | $0 | |
| Net Change in Cash | $-3M | $736.0K | $-2M | $-2M | $-2M | $10M | $-2M | $-3M | $3M | $-2M | $-2M | $-3M | $-5M | $-5M | $7M | $-2M | |
| Free Cash Flow | $-3M | · | · | · | · | · | · | · | $-3M | · | · | · | $-5M | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -15327.8% | · | -10576.9% | -9410.7% | -7878.4% | · | -14450.0% | -8693.3% | -8682.0% | · | -73600.0% | · | -5593.3% | · | -2564.1% | -4355.8% | |
| Net Margin | -7433.3% | · | -10350.0% | -9089.3% | -7683.8% | · | -14362.5% | -8496.7% | -8574.4% | · | -72080.0% | · | -5370.7% | · | -2491.6% | -4313.0% | |
| EBITDA Margin | -15105.6% | · | -10576.9% | -9410.7% | -7713.5% | · | -14450.0% | -8693.3% | -8502.6% | · | -73600.0% | · | -5504.0% | · | -2564.1% | -4355.8% | |
| ROA | -16.9% | · | -49.8% | -31.0% | -26.5% | · | -54.2% | -28.5% | -27.6% | · | -21.2% | -20.4% | -17.8% | · | -10.8% | -10.4% | |
| ROE | -37.2% | · | -112.0% | -47.4% | -35.1% | · | -105.3% | -42.0% | -36.3% | · | -25.3% | -23.9% | -20.4% | · | -12.2% | -11.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | · | 2.4 | 3.1 | 4.5 | · | 0.7 | 2.0 | 3.6 | · | 3.7 | 5.2 | 6.6 | · | 15.7 | 17.5 | |
| Quick Ratio | 0.9 | · | 1.7 | 2.7 | 4.2 | · | 0.4 | 1.3 | 3.1 | · | 3.1 | 4.8 | 6.2 | · | 14.7 | 16.7 |
Eficiencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.6 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.7 | 0.4 | · | 0.1 | 0.0 | 0.6 | · | 3.4 | · |
Por Acción
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.73 | · | $1.70 | $2.71 | $3.67 | · | $0.02 | $0.24 | $0.46 | · | $0.63 | $0.97 | $1.35 | · | $2.56 | $2.87 | |
| Revenue / Share | $0.00 | · | $0.01 | $0.01 | $0.01 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.01 | · | $0.01 | $0.01 | |
| Cash Flow / Share | $-0.61 | · | · | · | $-1.57 | · | · | · | $-0.20 | · | · | · | $-0.61 | · | · | · | |
| Cash / Share | $0.52 | · | $1.64 | $2.56 | $3.48 | · | $0.07 | $0.21 | $0.43 | · | $0.54 | $0.87 | $1.23 | · | $2.32 | $1.52 | |
| EPS (TTM) | $-4.46 | · | $1.85 | $0.60 | $-0.10 | · | $-24.63 | $-22.75 | $-21.53 | · | $-2.18 | $-2.15 | $-2.07 | · | $-1.35 | $-1.38 |
Valoración (TTM)
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112.0K | · | $142.0K | $140.0K | $142.0K | · | $122.0K | $103.0K | $73.0K | · | $242.0K | $368.0K | $445.0K | · | $2M | $2M | |
| Net Income TTM | $-12M | · | $-1M | $-2M | $-2M | · | $-12M | $-13M | $-14M | · | $-19M | $-19M | $-18M | · | $-12M | $-12M | |
| Market Cap | $3M | · | $5M | $8M | $4M | · | $95M | $94M | $131M | · | $131M | $131M | $177M | · | $147M | $214M | |
| P/E | -0.2 | · | 1.0 | 4.9 | -14.7 | · | -0.2 | -0.3 | -0.4 | · | -6.1 | -7.0 | -9.8 | · | -12.5 | -17.8 | |
| P/S | 30.5 | · | 33.2 | 54.4 | 26.9 | · | 775.2 | 913.0 | 1795.7 | · | 541.5 | 355.4 | 397.3 | · | 86.3 | 135.9 | |
| P/B | -1.5 | · | 1.1 | 1.1 | 0.4 | · | 259.8 | 25.6 | 19.7 | · | 21.2 | 15.5 | 15.0 | · | 6.6 | 8.6 | |
| P / Tangible Book | · | · | 1.1 | 1.1 | 0.4 | · | 259.8 | 25.6 | 19.7 | · | 21.2 | 15.5 | 15.0 | · | 6.6 | 8.6 | |
| P / Cash Flow | -1.1 | · | · | · | -1.0 | · | · | · | -43.9 | · | · | · | -33.3 | · | · | · | |
| Earnings Yield | -416.8% | · | 102.2% | 20.5% | -6.8% | · | -446.2% | -371.7% | -236.1% | · | -16.4% | -14.3% | -10.2% | · | -8.0% | -5.6% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Ingresos | $131.0K | $144.0K | $109.0K | $370.0K | $2M |
| Margen Operativo % | -8768.7% | · | · | · | -765.3% |
| Beneficio neto | $-14M | $-2M | $-15M | $-17M | $-11M |
| EPS Diluido | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Ratio corriente | 2.4 | · | · | · | 21.4 |
| Ratio Rápido | 1.8 | · | · | · | 20.7 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-11M | · | · | · | $-9M |
Propietarios institucionales (13F) 26 declarantes · $131K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
26
Valor en tenencia
$131K
Nuevas posiciones
4
Posiciones cerradas
3
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 4 (-1 vs trimestre anterior) | 3 (-4 vs trimestre anterior) | 2 (-2 vs trimestre anterior) | 5 (+3 vs trimestre anterior) | +5K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $40 497 | 22 374 | 30,86% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $27 795 | 25 976 | 21,18% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $19 795 | 18 500 | 15,09% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $16 447 | 15 371 | 12,53% | Acciones |
| BlackRock, Inc. | $12 644 | 11 817 | 9,64% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $7 493 | 7 003 | 5,71% | Acciones |
| Tower Research Capital LLC (TRC) | $5 616 | 5 249 | 4,28% | Acciones |
| SBI Securities Co., Ltd. | $236 | 221 | 0,18% | Acciones |
| Larson Financial Group LLC | $178 | 166 | 0,14% | Acciones |
| ALBION FINANCIAL GROUP /UT | $171 | 159 | 0,13% | Acciones |
| WELLS FARGO & COMPANY/MN | $119 | 111 | 0,09% | Acciones |
| OSAIC HOLDINGS, INC. | $88 | 84 | 0,07% | Acciones |
| MORGAN STANLEY | $52 | 49 | 0,04% | Acciones |
| UBS Group AG | $20 | 18 | 0,02% | Acciones |
| HRT FINANCIAL LP | $19 | 18 319 | 0,01% | Acciones |
| Caitong International Asset Management Co., Ltd | $18 | 17 | 0,01% | Acciones |
| IFG Advisory, LLC | $15 | 14 | 0,01% | Acciones |
| Rockefeller Capital Management L.P. | $2 | 2 | 0,00% | Acciones |
| Golden State Wealth Management, LLC | $2 | 2 | 0,00% | Acciones |
| Federation des caisses Desjardins du Quebec | $2 | 2 | 0,00% | Acciones |
| Activest Wealth Management | $2 | 2 | 0,00% | Acciones |
| HARBOUR INVESTMENTS, INC. | $1 | 1 | 0,00% | Acciones |
| First Command Advisory Services, Inc. | $1 | 1 | 0,00% | Acciones |
| Hilton Head Capital Partners, LLC | $1 | 1 | 0,00% | Acciones |
| FNY Investment Advisers, LLC | $0 | 200 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $0 | 1 | 0,00% | Acciones |
Informantes de la empresa 31 insiders · 14 directivos · 17 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Taylor Crouch | CEO & President | 18 de agosto de 2020 F | 125 144 | 0 | 0 | $0 |
| Craig Kussman | Chief Financial Officer | 18 de agosto de 2020 F | 221 743 | 0 | 0 | $0 |
| Barry D Michaels | Chief Financial Officer | 24 de agosto de 2015 A | 86 808 | 0 | 0 | $0 |
| Tony Serge Lialin | Chief Commercial Officer | 31 de agosto de 2026 P | 10 000 | 1 | 0 | $2 800 |
| Murphy Keith | EXECUTIVE CHAIRMAN | 27 de enero de 2026 A | 26 053 | 0 | 0 | $0 |
| Amar Akhtar Sethi | Chief Scientific Officer | 25 de noviembre de 2025 A | · | 0 | 0 | $0 |
| Jeffrey N. Miner | Chief Scientific Officer | 31 de agosto de 2022 A | · | 0 | 0 | $0 |
| Thomas E Jurgensen | General Counsel & Secretary | 31 de agosto de 2022 A | · | 0 | 0 | $0 |
| Jennifer Bush | General Counsel & Secretary | 18 de agosto de 2020 F | 192 758 | 0 | 0 | $0 |
| Steven George Hughes | Chief Medical Officer | 16 de agosto de 2019 S | 138 484 | 0 | 0 | $0 |
| Paul Gallant | General Manager | 16 de agosto de 2019 F | 191 335 | 0 | 0 | $0 |
| Sharon Collins Presnell | Chief Scientific Officer | 16 de noviembre de 2018 F | 280 993 | 0 | 0 | $0 |
| Eric David | CSO & EVP Pre-Clinical Dev | 16 de noviembre de 2017 F | 876 609 | 0 | 0 | $0 |
| Michael Renard | EVP of Commercial Operations | 4 de junio de 2015 A | 50 000 | 0 | 0 | $0 |
| David Gobel | Consejero | 27 de enero de 2026 A | 15 000 | 0 | 1 | $-7 316 |
| Alison Tjosvold Milhous | Consejero | 27 de enero de 2026 A | 19 899 | 0 | 0 | $0 |
| Douglas Jay Cohen | Consejero | 27 de enero de 2026 A | 20 732 | 0 | 0 | $0 |
| Adam K Stern | Consejero | 27 de enero de 2026 A | 19 899 | 0 | 0 | $0 |
| Vaidehi Joshi | Consejero | 7 de agosto de 2024 A | 58 821 | 0 | 0 | $0 |
| David Shapiro | Consejero | 5 de septiembre de 2019 A | · | 0 | 0 | $0 |
| Richard E Maroun | Consejero | 5 de septiembre de 2019 A | 15 000 | 0 | 0 | $0 |
| Carolyn Beaver | Consejero | 5 de septiembre de 2019 A | · | 0 | 0 | $0 |
| Kirk Malloy | Consejero | 5 de septiembre de 2019 A | 7 500 | 0 | 0 | $0 |
| Mark Kessel | Consejero | 5 de septiembre de 2019 A | 15 000 | 0 | 0 | $0 |
| Robert Baltera Jr. | Consejero | 26 de julio de 2018 A | 146 006 | 0 | 0 | $0 |
| James T Glover | Consejero | 26 de julio de 2018 A | 17 500 | 0 | 0 | $0 |
| Tamar D Howson | Consejero | 26 de julio de 2018 A | 7 500 | 0 | 0 | $0 |
| Richard A. Heyman | Consejero | 20 de agosto de 2015 A | · | 0 | 0 | $0 |
| Andras Forgacs | Consejero | 18 de octubre de 2012 A | · | 0 | 0 | $0 |
| Chris Heberlig | · | 15 de septiembre de 2020 A | · | 0 | 0 | $0 |
| Kevin Kimberlin | · | 27 de septiembre de 2012 J | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 15 371 SH | 19 de agosto de 2026 | Diario |
VIVS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 7 analistas
VENTA
0 0,0%
Compra fuerte
0 0,0%
Compra
4 57,1%
Mantener
1 14,3%
Venta
2 28,6%
Venta fuerte
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | · |
| HCWB | · | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| MBIO | · | -2.5 | · | · | -30.9% | · |
| DCOY | · | -0.0 | · | · | · | · |
| GOVX | $296.2K | · | -37.1% | -862.3% | -645.9% | · |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| ADTX | $343.6K | -0.0 | -97.6% | -1349028.2% | -1183.4% | 8.4% |
| APVO | $9M | -0.1 | · | · | -217.2% | · |
| REVB | · | · | · | · | · | · |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026